Related Experiment Video

Updated: Dec 19, 2025

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

10.5K

Activation of sarcolipin expression and altered calcium cycling in LMNA cardiomyopathy

Blanca Morales Rodriguez1,2, Alejandro Domínguez-Rodríguez3, Jean-Pierre Benitah3

  • 1Sorbonne Université, INSERM UMRS974, Paris, France.

Biochemistry and Biophysics Reports
|June 4, 2020
PubMed

Insights

Researchers found elevated sarcolipin in hearts with LMNA cardiomyopathy, disrupting calcium handling. Reducing sarcolipin levels delayed cardiac dysfunction in a mouse model, suggesting a new therapeutic target for this heart condition.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • LMNA cardiomyopathy, caused by mutations in the A-type lamins gene, leads to heart failure with poor prognosis.
  • No specific therapies currently exist for LMNA cardiomyopathy.
  • Calcium homeostasis is crucial for cardiac function and may play a role in disease progression.

Purpose of the Study:

  • To investigate the role of calcium homeostasis in the development of LMNA cardiomyopathy.
  • To identify potential therapeutic targets for halting the progression of LMNA cardiomyopathy.

Main Methods:

  • Studied sarcolipin levels in ventricular cardiomyocytes of a mouse model of LMNA cardiomyopathy.
  • Utilized adeno-associated virus (AAV) 9-mediated RNA interference to downregulate sarcolipin.
  • Assessed cardiac function and calcium handling alterations.

Main Results:

  • Sarcolipin, a SERCA inhibitor, was found to be abnormally elevated in mutated mice, indicating altered calcium handling.
  • This elevation occurred early in the disease, before significant left ventricular dysfunction.
  • Downregulation of sarcolipin using AAV9-RNAi delayed cardiac dysfunction in the mouse model.

Conclusions:

  • Sarcolipin plays a significant role in calcium homeostasis disruption in LMNA cardiomyopathy.
  • Targeting sarcolipin presents a novel therapeutic strategy for LMNA cardiomyopathy.
  • Further research into sarcolipin's role could lead to effective interventions for this severe heart condition.

Keywords:
Calcium handlingDilated cardiomyopathyLMNANuclear envelopeSarcolipin

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.1K
Analyzing the α-Actinin Network in Human iPSC-Derived Cardiomyocytes Using Single Molecule Localization Microscopy07:02

Analyzing the α-Actinin Network in Human iPSC-Derived Cardiomyocytes Using Single Molecule Localization Microscopy

Published on: November 3, 2020

7.0K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
268
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
341
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
325